Direct-to-consumer sales of medications often mean lower prices and more convenience for patients.

One of the biggest gripes around weight loss medications like Wegovy and Zepbound is the high price tag. At $1,000 or more a ...

Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted ...

Trump's deal slashes GLP-1 drug costs for Medicare beneficiaries and others, unlocking coverage for millions with obesity and ...

Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...

Medicare will cover GLP-1 weight loss drugs for specific patient groups, beginning in mid-2026, under a deal struck with drugmakers.

P opular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump ...

Medicare coverage will cut obesity-drug prices but open the door to millions of new patients.

There’s plenty to like about the lower direct-to-consumer prices the White House negotiated with Eli Lilly and Novo Nordisk.

When a man suddenly collapsed during a televised White house event about weight-loss drugs, it sparked widespread speculation ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.